| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3122989 | T | Selectivity index, ratio of CC50 for cytotoxicity to EC50 for Influenza A virus H5N1 | 8 | assay format | Scientific Literature | |||
| 2. | ALA3122991 | T | Selectivity index, ratio of CC50 for cytotoxicity to EC50 for Influenza A virus H3N2 | 8 | assay format | Scientific Literature | |||
| 3. | ALA3122992 | T | Selectivity index, ratio of CC50 for cytotoxicity to EC50 for Influenza B virus | 8 | assay format | Scientific Literature | |||
| 4. | ALA3122993 | T | Selectivity index, ratio of CC50 for cytotoxicity to EC50 for HSV2 | 8 | assay format | Scientific Literature | |||
| 5. | ALA3122994 | T | Selectivity index, ratio of CC50 for cytotoxicity to EC50 for SARS coronavirus | 7 | assay format | Scientific Literature | |||
| 6. | ALA3122995 | T | Selectivity index, ratio of CC50 for cytotoxicity to EC50 for HSV1 | 8 | assay format | Scientific Literature | |||
| 7. | ALA3122996 | F | Antiviral activity against Influenza A virus H5N1 by cytopathy assay | Influenza A virus | 8 | organism-based format | Scientific Literature | ||
| 8. | ALA3122997 | F | Antiviral activity against Influenza A virus H1N1 by cytopathy assay | Influenza A virus | 8 | organism-based format | Scientific Literature | ||
| 9. | ALA3122998 | F | Antiviral activity against Influenza B virus by cytopathy assay | Influenza B virus | 8 | organism-based format | Scientific Literature | ||
| 10. | ALA3122999 | F | Antiviral activity against Influenza A virus H3N2 by cytopathy assay | Influenza A virus | 8 | organism-based format | Scientific Literature | ||
| 11. | ALA3123269 | F | Antiviral activity against West Nile virus by visual/neutral red test | West Nile virus | 7 | organism-based format | Scientific Literature | ||
| 12. | ALA3123270 | F | Antiviral activity against SARS coronavirus by visual/neutral red test | Severe acute respiratory syndrome-related coronavirus | 6 | organism-based format | Scientific Literature | ||
| 13. | ALA3123271 | F | Antiviral activity against HSV1 assessed as inhibition of viral infection | Human alphaherpesvirus 1 | 8 | organism-based format | Scientific Literature | ||
| 14. | ALA3123272 | F | Antiviral activity against HSV2 assessed as inhibition of viral infection | Human alphaherpesvirus 2 | 8 | organism-based format | Scientific Literature | ||
| 15. | ALA3123273 | F | Antiviral activity against Hepatitis C virus assessed as inhibition of viral infection by RNA replicon assay | Hepacivirus hominis | 8 | organism-based format | Scientific Literature | ||
| 16. | ALA3123274 | F | Antiviral activity against Hepatitis B virus assessed as inhibition of viral infection by DNA virion assay | Hepatitis B virus | 8 | organism-based format | Scientific Literature | ||
| 17. | ALA3123275 | F | Antimicrobial activity against Aspergillus viridinutans at 250 ug/disc after 5 to 7 days by well diffusion method | Aspergillus viridinutans | 17 | assay format | Scientific Literature | ||
| 18. | ALA3123276 | F | Antimicrobial activity against Aspergillus niger at 250 ug/disc after 5 to 7 days by well diffusion method | Aspergillus niger | 17 | organism-based format | Scientific Literature | ||
| 19. | ALA3123277 | F | Antimicrobial activity against Escherichia coli at 250 ug/disc after 48 hrs by well diffusion method | Escherichia coli | 17 | organism-based format | Scientific Literature | ||
| 20. | ALA3123278 | F | Antimicrobial activity against Bacillus subtilis at 250 ug/disc after 48 hrs by well diffusion method | Bacillus subtilis | 17 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!